Internalized stigma group for Psychosis

Waitlist Available
Led By Christopher R Bowie, PhD
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Not abusing drugs or alcohol
Diagnosis of schizophrenia, schizoaffective disorder or any other psychotic disorder
Must not have
Be younger than 18 years old
Be older than 65 years old
Screening 3 weeks
Treatment Varies
Follow Upparticipants will be assessed at baseline, and assessed for changes immediately following the treatment and at 6 months and 12 months post treatment.
Awards & highlights
No Placebo-Only Group

Study Summary

This trial looks at an intervention to help people with psychosis who also have to deal with the negative stereotypes they've internalized about their condition. The intervention is aimed at helping with self-esteem and quality of life. The proposed research would expand the program and make it available to more people.

Eligible Conditions
  • Psychosis
  • Schizophrenia

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You do not abuse drugs or alcohol.
You have been diagnosed with a severe mental illness like schizophrenia or schizoaffective disorder.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~participants will be assessed at baseline, and assessed for changes immediately following the treatment and at 6 months and 12 months post treatment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and participants will be assessed at baseline, and assessed for changes immediately following the treatment and at 6 months and 12 months post treatment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Internalized stigma
Secondary outcome measures
Generalized Anxiety Disorder scale (GAD-7)
Interpersonal Hopelessness Scale
Interpersonal Needs Questionnaire
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Internalized stigma groupExperimental Treatment1 Intervention
BOOST is an 8 session group intervention, delivered over 4 weeks. The program uses evidence based therapeutic techniques and integrates cognitive behavioural therapy and peer support to reduce or prevent the internalization of stigma in early psychosis. Sessions 1-4 focus on dispelling stigmatizing myths about psychosis and evaluating the accuracy of group members or societies stigmatizing beliefs in order to normalize experiences associated with and reactions to the symptoms of psychosis. Sessions 5-8 teach behavioural approaches for self-empowerment through social skills training, development of assertiveness skills, and goal setting. Role-plays that are specific to young people with psychosis, which were co-developed with people with lived experience, provide opportunities to practice these skills in session. During role plays, participants monitor stigmatizing beliefs that may interfere with communication or pursuing goals.

Find a site

Who is running the clinical trial?

Queen's UniversityLead Sponsor
355 Previous Clinical Trials
118,761 Total Patients Enrolled
2 Trials studying Psychosis
373 Patients Enrolled for Psychosis
Christopher R Bowie, PhDPrincipal Investigator
Queen's University
1 Previous Clinical Trials
75 Total Patients Enrolled

Media Library

Self-stigma intervention Clinical Trial Eligibility Overview. Trial Name: NCT05571228 — N/A
Psychosis Research Study Groups: Internalized stigma group
Psychosis Clinical Trial 2023: Self-stigma intervention Highlights & Side Effects. Trial Name: NCT05571228 — N/A
Self-stigma intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05571228 — N/A
Psychosis Patient Testimony for trial: Trial Name: NCT05571228 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can I join the experimental program being conducted?

"This trial requires 100 participants aged 18-35 that have been clinically diagnosed with a psychotic disorder, such as schizophrenia or schizoaffective disorder. Furthermore, they must be competent in spoken and written English, computer skills and telephone operations; excluding those who use drugs or alcohol to excess."

Answered by AI

Is recruitment for the experiment still taking place?

"This particular medical experiment is no longer recruiting participants, having been first posted on October 1st 2020 and recently updated on the 04th of October 2022. However, 641 other clinical trials remain open to enrollees."

Answered by AI

Is the stipulated age range for this clinical trial inclusive of septuagenarians?

"This medical trial is specifically seeking participants aged 18 to 35. Those under the age of consent have 138 different studies available and adults over 65 can choose from 364 separate research efforts."

Answered by AI

Who else is applying?

What state do they live in?
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
What site did they apply to?
Queen's University

Why did patients apply to this trial?

Looking for a better solution.
~5 spots leftby Dec 2023